The discovery of natalizumab, a potent therapeutic for multiple sclerosis
Multiple sclerosis (MS) is the major inflammatory demyelinating disease of the central nervous system. There is strong evidence that an immune response in the brain is a critical component of the disease. In 1992, in a collaboration between academia and biotechnology, my colleagues and I showed that...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Rockefeller University Press
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483125/ |